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1. Introduction 
Typhoid fever, also known as enteric fever, is a potentially fatal multi systemic illness 
caused primarily by Salmonella enterica serotype Typhi (S. Typhi). The classic presentation 
of the disease includes fever, malaise, diffuse abdominal pain, and constipation. Untreated, 
typhoid fever may progress to severe condition like delirium, intestinal hemorrhage, bowel 
perforation, and death. The disease remains a critical public health problem in developing 
countries. In 2000, it was estimated that over 2,16 million of typhoid occurrences worldwide, 
resulting in 216,000 deaths, and that more than 90% of this morbidity and mortality 
occurred in Asia [1]. A report from World Health Organization in 2008 on typhoid fever in 
five Asian countries showed the annual typhoid incidence (per 100,000 person years) among 
5-15 years age group varied from 24.2 and 29.3 in Vietnam and China, to 180.3 in Indonesia; 
and to 412.9 and 493.5 in Pakistan and India, respectively; multidrug resistant S. Typhi were 
23% (96/413) [2]. Further, unlike S. Typhi originated from Pakistan, Vietnam and India, 
those from Indonesia collected in North Jakarta, were all susceptible to antibiotic tested, i.e. 
Chloramphenicol, Ampicillin, Trimethoprim-Sulfamethoxazole; none of multidrug 
resistance were found. Nalidixic acid resistance was rather high in Pakistan, India and 
Vietnam, but none was found in Indonesia [2].  
In Indonesia the prevalence of typhoid fever was 358-810 per 100,000 populations in 2007, with 
64% of the disease was found in people aged 3-19 years. Mortality rate varies from 3.1-10.4% 
among hospitalized patients. Hatta and Ratnawati, 2008 reported a rise of resistance of S. 
Typhi to 6.8% to all three of first line drugs (Chloramphenicol, Ampicillin, Co-trimoxazole) in 
South Sulawesi (East of Indonesia) [3]. Antibiotics Fluoroquinolone and 3rd generation of 
Cephalosporin are frequently used for therapy of patients suspected typhoid fever in the past 
decade in many places especially in endemic countries including Indonesia due to resistance 
issues against conventional antibiotics [4, 5, 6, 7]. This study aimed to overview antibiotic 
susceptibility of S. Typhi originated from Jakarta and surrounding areas in particular to those 
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recommended by Performance Standard for Antimicrobial Susceptibility Testing for Clinical 
and Laboratory Standard Institute within 9 years period up to 2010.  
2. Materials and methods 
2.1 Specimens 
Specimens used in the study were blood received in our laboratory i.e. Laboratory of 
Clinical Microbiology Faculty of Medicine University of Indonesia (CML-FMUI) Jakarta 
between 2002-2007. Our laboratory accepted specimens from hospitals, mainly the National 
Hospital Cipto Mangunkusumo (a tertiary general public hospital), primary health cares, 
private practices, and individuals. As in CML-FMUI, blood specimens from in and 
outpatients as well as other sources examined in Siloam Hospital Kebon Jeruk and St. 
Carolus Private Hospital in 2008-2010 were also included.  
2.2 Culture and antibiotic susceptibility tests 
Culture and antibiotic susceptibility tests were established in each of the above-mentioned 
institutions. Microbiology tests were performed according to microbiology standard 
practices and Performance Standards for Antimicrobial Susceptibility Testing for the 
Clinical and Laboratory Standards Institute (CLSI) [8]. Cultures were performed using 
Bac-T AlertTM (Enseval)/BactecTM 9050 (Becton Dickinson), and sub cultured were on 
Salmonella-Shigella and MacConkey agar. Microorganism identification was determined 
using conventional biochemical reactions i.e. acid production from glucose, lactose, 
maltose, mannitol and saccharose, IMViC tests (Indole, Methyl Red, Voges Proskauer and 
Citrate) and H2S production in TSI agar. In recent years, API20E biochemical 
identification system (BioMerieux, Paris, France) was used instead. Susceptibility of 
microorganisms to antibiotics was assessed using the disc diffusion method. 
Antimicrobial susceptibility results were categorized in to three groups: Sensitive (S), 
Intermediate (I) and Resistant (R) according to CLSI guidelines. The antibiotics 
susceptibility data was then entered into the WHO-Net 5.4 program. 
2.3 Antibiotics  
Standard disc diffusion method was employed. The following antibiotic discs 
Chloramphenicol (CHL) 30µg, Amoxycillin (AMX) 25µg, Trimethoprim-Sulfamethoxazole 
(SXT) 1.25/23.75µg, Ceftriaxone (CRO) 30µg, Ciprofloxacin (CIP) 5µg, and Levofloxacin 
(LVX) 5µg were included in the study. These antibiotics are frequently used to treat typhoid 
fever in Jakarta, Indonesia. Susceptibility of S. Typhi to antibiotics was tabulated, and good 
activity in-vitro was defined by antimicrobial susceptibility of 80% or greater. Minimal 
inhibitory concentration was not examined. 
3. Results  
During nine years period from 2002-2010, 247 isolates of S. Typhi were collected, in which 
35 isolates were from CML-FMUI, 73 and 139 isolates came from Siloam Kebon Jeruk and St. 
Carolus Hopitals respectively. In 2002-2007, all S. Typhi isolated in CML-FMUI was 
susceptible to antibiotics Levofloxacin, Ciprofloxacin, Trimethoprim-Sulfamethoxazole and 
www.intechopen.com
 
Antibiotic Susceptibility Patterns of Salmonella Typhi in Jakarta and Surrounding Areas  
 
93 
Amoxycillin (Figure 1). In 2008-2010, all of S. Typhi isolated in Siloam Hospital Kebon 
Jeruk was susceptible to Levofloxacin and Ciprofloxacin as also found in St. Carolus 
Hospital except antibiotic Levofloxacin was not tested on isolates from St. Carolus 
Hospital (see Figure 1). Susceptibility of the microorganism to Trimethoprim-
Sulfamethoxazole showed almost similar pattern to those of CML-FMUI in the earlier 
years ranging from 98.6% to 100%, and so Amoxycillin that was 98.5% to 100%. 
Susceptibility of these microorganisms to Ceftriaxone seemed to increase from 92.6% in 
2002-2007 to 98.6% or greater in 2008-2010. Lastly, although antibiotic Chloramphenicol 
was scarcely used in the treatment of typhoid fever compared to Fluoroquinolones, this 
antibiotic was still effective. The susceptibility of S. Typhi isolates to Chloramphenicol 
was 94.1% in 2002-2007, and was apparently increase to 98.6% or greater in 2008-2010 
(Figure 1). Overall, during 9 years period up to 2010, antibiotic Chloramphenicol, 
Amoxycillin, Trimethoprim-Sulfamethoxazole, Ceftriaxone, Ciprofloxacin and 
Levofloxacin showed good activity in-vitro against S. Typhi originated from Jakarta and 
adjacent areas.  
 
Fig. 1. Susceptibility of S.Typhi to Antibiotics in Jakarta and Surrounding Areas  
4. Discussions 
Jakarta, as a capital city, is the biggest urban area in Indonesia. The city connects to five 
other satellites cities i.e. Bogor, Depok, Tangerang, Bekasi, Karawang, and it is densely 
populated where some districts are still impoverished. Health care system in the country 
does not support extensive program that covers laboratory examinations. This reflected in 
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the limited samples received in the laboratories. Clinical Microbiology Laboratory of Faculty 
of Medicine University of Indonesia is located in the center of Jakarta and known as the 
referral Microbiology Laboratory as it is part of the Department of Microbiology FMUI. The 
laboratory receives specimens from other laboratories, hospitals, primary health cares and 
also individuals. Furthermore, Siloam Kebon Jeruk in West Jakarta and St. Carolus in 
Central Jakarta are private hospitals; their laboratories serve for the hospitalized, outpatients 
and also other sources. In this study, 247 isolates of S. Typhi examined during 2002-2010 
were susceptible to antibiotics Chloramphenicol, Amoxycillin, Trimethoprim-
Sulfamethoxazole, Ceftriaxone, Ciprofloxacin, and Levofloxacin. In addition, S. Typhi was 
in fact still susceptible to antibiotic Tetracycline (Data not shown).  
Some reports on antibiogram of S. Typhi from other institutions within the country were 
similar i.e. Central Laboratory of Cipto Mangunkusumo Hospital reported all S. Typhi isolated 
from hospitalized typhoid fever cases in 2009 were all susceptible to antibiotics 
(Chloramphenicol, Cotrimoxazole, Ceftriaxone, Cefuroxime, Ampicillin-Sulbactam, 
Amoxycillin-Clavulanic acid, Ciprofloxacin, Levofloxacin) [9]. In 2003-2005, ninety isolates of 
S. Typhi were collected from some districts in East Jakarta. All of these isolates were 
susceptible to first line drugs (Chloramphenicol, Trimethoprim-Sulfamethoxazole, Ampicillin) 
and Tetracycline except for only 1 isolate which was resistant to Chloramphenicol [10].  
Data obtained from outside Jakarta such from Pakanbaru in Sumatra Island in 2009-2010 
also showed very similar susceptibility patterns. Those S. Typhi isolates were all 
susceptible to Chloramphenicol, Tetracycline, Trimetoprim-Sulfamethoxazole, 
Amoxycillin-Clavulanic Acid, Cefotaxim, Cefepime, Ceftazidime, Cefazolin, Ceftriaxone 
and Ciprofloxacin [11]. S. Typhi isolated from South Sulawesi, however, showed an 
increase resistant against Chloramphenicol and Ciprofloxacin between 2001-2007, which 
was 1.04% to 7.84% and 0.11% to 6.83% respectively [3]. In 2003, a collaborated study on 
enteric bacteria in patients with diarrhea had been carried out in United States Naval 
Medical Research Unit, Jakarta that involved many health institutions from many cities in 
Indonesia including Medan, Padang, Batam, Jakarta, Pontianak, Denpasar and Makassar. 
A total of 111 S. Typhi had been isolated from feces, and all were susceptible to antibiotic 
tested i.e. Ampicillin, Trimethoprim-Sulfamethoxazole, Chloramphenicol, Tetracyclin, 
Cephalotin, Ceftriaxone, Norfloxacin and Ciprofloxacin. Nalidixic acid resistance was not 
found [12]. 
Resistance to Chloramphenicol was reported to emerge in only two years after its 
introduction in 1948, and was not until 1972 that typhoid fever caused by Chloramphenicol-
resistant S. Typhi became a major problem; outbreaks occurred in Mexico, India, Vietnam, 
Thailand, Korea, and Peru (cited from Parry et al, 2002 [13]). Toward the end of the 1980s 
and the 1990s, S. Typhi developed resistance simultaneously to all the drugs that were then 
used as first line treatment (Chloramphenicol, Trimethoprim, Sulfamethoxazole, and 
Ampicillin). Despite multidrug-resistant S. Typhi are still common in many areas of Asia, 
strains that are fully susceptible to all first line antibiotics have reemerged in some areas 
[13]. Chau et al, 2007 reported that of eight endemic countries from Indian continent to 
China, multidrug resistance (MDR) S. Typhi varied from 16 to 37% and Nalidixic acid 
resistance were 5 to 51% [7]. In some places Nalidixic Resistant S. Typhi (NRST) was 
reported to cause more complication and poorer outcome of the disease; the presence of 
NRST is critical and influenced the successful rate of therapy with Fluoroquinolone [14]. 
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Despite an increase resistance elsewhere, certain areas especially in Northern India, reported 
that Chloramphenicol resistance has reduced from a high of 18% to only 2% [15].  
Differences in the antibiotic susceptibility profiles as well as clinical appearance of typhoid 
fever cause by S. Typhi rely on many factors. Conditions such as disease control programs, 
inadequate policy of using antibiotics, local conditions that include personal hygiene, 
availability of clean drinking water, food handling and sanitation contribute to the 
complexity and outcome of the disease. Nevertheless, one important element of the diverse 
clinical manifestation of typhoid fever is the presence of genome plasticity of S. Typhi. Many 
studies had been conducted in the late nineties on genome profile of S. Typhi and showed 
the diversity of the genome. Some of strains originated from a certain region or country 
share some degree of similarity to other strains from different places. Our earlier study on 
genetic relationship using pulsed-field gel electrophoresis (PFGE) found that S. Typhi 
originated from five cities i.e. Medan, Jakarta, Pontianak, Makassar and Jayapura in 
Indonesia expanding from west to east part of the country, had clusters of endemic strains 
in certain geographic areas [16]. The presence of specific strains in localized area might have 
been the reason of varied symptoms of the disease and, possibly their susceptibility to 
antibiotics. Despite heterogeneity and different clonality of the 33 isolates of S. Typhi used 
in the study, these endemic strains were in fact all susceptible to Chloramphenicol, 
Ampicillin and Cotrimoxazole [16]. 
Some investigators reported a correlation of certain genome profiles of S. Typhi strains and 
their ability to cause a fatal typhoid fever [17]. Others reported specific flagellar types were 
associated with severe outcome of the disease [18]. A study carried out in our laboratory by 
Tjita in 2000 showed that 3 S. Typhi strains had identical genome profiles deduced from 
PFGE [19]. Each of the strains showed different susceptibility against several antibiotics i.e. 
one strain was resistant to Tetracycline; another two were multi resistant to 
Chloramphenicol/Tetracycline, and Ampicillin/Chloramphenicol/ Tetracycline 
respectively (see Figure 2). In addition to the findings, two other S. Typhi strains which 
resistant to Ampicillin and Tetracycline were found to be an identical strains [19]. The 
mentioned conditions could have been the reasons that conventional drugs such as 
Chloramphenicol, Amoxycillin, Trimethoprim- Sulfamethoxazole and Tetracyclin still have 
good activity in-vitro against S. Typhi strains in Jakarta and surrounding areas. In recent 
years, antibiotic Fluoroquinolone has been widely used in the treatment of typhoid fever in 
Indonesia, and it showed superiority in term of efficacy and safety [20]. Previous reports by 
Ochiai et al, 2008 [2] and Tjaniadi et al, 2003 [12] showed Nalidixic acid resistant S. Typhi 
was not found thus far in Indonesia. Cautious is adviced, however, since quinolone resistant 
S. Typhi strains have been an important issue in regional and global [6, 21, 22, 23].  
In conclusion, despite resistance issue of S. Typhi from other countries, this study showed 
that most of all S. Typhi isolated in certain places in Jakarta and neighboring areas were 
susceptible to antibiotic tested (Chloramphenicol, Amoxycillin, Trimethoprim- 
Sulfamethoxazole, Ceftriaxone, Ciprofloxacin, Levofloxacin). This information is important 
since antimicrobial therapy plays a key role in management of typhoid fever disease. The 
susceptibility profiles, however, were only derived from certain strains, which may not 
represent all strains, which present in Indonesia. Therefore it is necessary to perform 
cultures and antibiotic sensitivity tests on patients with suspected typhoid fever, and so the 
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patients can be treated with definitive antibiotic therapy. Needless to say, adequate 
antibiotic therapy will prevent the spread of antibiotic-resistant S. Typhi strains. Lastly, 
promotion of public health such as personal hygiene, sanitations, clean drinking water, food 
handlings and also vaccination are equally important as prevention of the disease. 
 
Sixteen S. Typhi isolates were originated from patients with typhoid fever in Jakarta. The genome was 
digested XbaI restriction enzyme. T6, T10 and T12 [ ] were identical strains, which showed different 
susceptibility patterns i.e. T6 resistant to Tetracycline, T10 resistant to Chloramphenicol/Tetracycline, 
T12 resistant to Ampicillin/Chloramphenicol/Tetracycline. T1 and T4 [ ] had identical genome 
profiles but each showed different susceptibility patterns i.e. T1 resistant to Ampicilin, and T4 resistant 
to Tetracycline. Modified from Tjita, 2000 [19]. 
Fig. 2. Genome profile of S. Typhi isolates from Jakarta using Pulsed-Field Gel 
Electrophoresis 
5. Acknowledgments 
We thank the staffs and technicians at the Clinical Microbiology Laboratory Department of 
Microbiology Faculty of Medicine University of Indonesia for their works and contributions 
to the study.  
www.intechopen.com
 
Antibiotic Susceptibility Patterns of Salmonella Typhi in Jakarta and Surrounding Areas  
 
97 
6. References 
[1] Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health 
Organ 2004; 82: 346-53. 
[2] Ochiai RL, Acosta CJ, Danovaro-Holliday MC, Baiqing D, Bhattacharya SK, Agtini MD, 
Bhutta ZA, Canh DG, Ali M, Shin S et al.  A study of typhoid fever in five Asian 
countries: disease burden and implications for controls. Bull World Health 
Organization 2008; 86: 260–268. 
[3] Hatta M and Ratnawati. Enteric Fever in endemic areas of Indonesia: an increasing 
problem of resistance. J Infect Developing Countries 2008; 2(4): 279-282. 
[4] Hasan R, Zafar A, Abbas Z, Mahraj V, Malik F and Zaidi A. Antibiotic resistance among 
Salmonella enterica serovars Typhi and Paratyphi A in Pakistan (2001-2006). J Infect 
Developing Countries 2008; 2(4): 289-294. 
[5] Kumar S, Rizvi M and Berry N. Rising prevalence of enteric fever due to multidrug- 
resistant Salmonella: an epidemiological study. Journal of Medical Microbiology 
2008; 57: 1247-1250. 
[6] Jin Yang. Enteric Fever in South China: Guangxi Province. J Infect Developing Countries 
2008; 2(4): 283-288. 
[7] Chau TT, Campbell JI, Galindo CM, Hoang NVM, Diep TS, Thi Nga TT, Chau NVV, 
Tuan PQ, Page AL, Ochiai RL et al. Antimicrobial Drug Resistance of Salmonella 
enterica Serovar Typhi in Asia and Molecular Mechanism of Reduced Susceptibility 
to the Fluoroquinolones. Antimicrobial Agents and Chemotherapy 2007; 51 (12): 
4315-4323. 
[8] Performance Standards for Antimicrobial Susceptibility Testing. Clinical and Laboratory 
Standard Institute (CLSI); year up to date. 
[9] Loho T. Microorganism mapping and their Susceptibility to antibiotics in National 
Hospital Cipto Mangunkusumo Jakarta in 2009. (Unpublished). 
[10] Ali S. Antibiotic Susceptibility of Salmonella Typhi in Jakarta in 2001-2003. 
(Unpublished). 
[11] Anggraini D. Susceptibility of Salmonella Typhi in Private Hospital in Pakanbaru 
Sumatra in 2010. (Unpublished). 
[12] Tjaniadi P, Lesmana M, Subekti D, Machpud N, Komalarini S, Santoso W, Simanjuntak 
CH, Punjabi N, Campbell JR, Alexander WK, Beecham III HJ, Corwin AL and 
Oyofo BA. Antimicrobial Resistance of Bacterial Pathogens Associated with 
Diarrheal Patients in Indonesia. Am J Trop Med Hyg 2003; 68 (6): 666-670. 
[13] Parry CM, Hien TT, Dougan G, White NJ and Farrar JJ. Typhoid Fever. Medical 
progress. N Engl J Med 2002; 347: 1770-1782. 
[14] Kadhiravan T, Wig N, Kapil A, Kabra SK, Renuka K and Misra A. Clinical outcomes in 
typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella 
Typhi. BMC Infectious Diseases 2005; 5:37. http://www.biomedcentral.com/1471-
2334/5/37 
[15] Shrikala Baliga. Drug Resistance in Salmonella typhi: Tip of the Iceberg. Online J Health 
Allied Scs. 2004; 4: 1. 
[16] Moehario LH. The molecular epidemiology of Salmonella typhi across Indonesia reveals 
bacterial migration. J Infect Dev Ctries 2009; 3(8): 579-584. 
www.intechopen.com
 
Salmonella – A Diversified Superbug 
 
98
[17] Thong KL, Passey M, Clegg A, Comb BG, Yassin RM, and Pang T. Molecular analysis of 
isolates of Salmonella Typhi obtained from patients with fatal and non fatal typhoid 
fever. J Clin Microbiol 1996; 34: 1029-1033. 
[18] Franco A, Gonzales C, Levine OS, Lagos R, Hall RH, Hoffman SL, Moechtar MA, 
Gotuzzo E, Levine M and Hone DM. Further consideration of the clonal nature of 
Salmonella typhi: Evaluation of molecular and clinical characteristics of strains from 
Indonesia and Peru. J Clin Microbiol 1992; 30(8): 2187-2190. 
[19] Tjita PJ. Analysis of genetic diversity of Salmonella typhi resistant against first line drugs 
using Pulsed-Field Gel Electrophoresis. (Magister Thesis in Biomedical Science, 
2000. Unpublished). 
[20] Nelwan RH, Chen K, Nafrialdi and Paramita D. Open study on efficacy of Levofloxacin 
in treatment of uncomplicated typhoid fever. Southeast Asian J Trop Med Public 
Health 2006; 37(1): 126-130. 
[21] Accou-Demartin M, Gaborieau V, Song Y, Roumagnac P, Marchou B, Achtman M, and 
Weill FX. Salmonella enterica Serotype Typhi with Non-classical Quinolone 
Resistance Phenotype Emerging Infectious Diseases 2011; 17(6): 1091-1094. 
[22] Keddy KH, Smith AM, Sooka A, Ismail H, and Oliver S. Fluoroquinolone-Resistant 
Typhoid, South Africa. Emerging Infectious Diseases 2010; 16(5): p. 880. 
[23] Joshi S and Amarnath SK. Fluoroquinolone resistance in Salmonella typhi and S. 
paratyphi A in Bangalore, India. Transactions of the Royal Society of Tropical 
Medicine and Hygiene 2007; 101(3): 308-310.  
www.intechopen.com
Salmonella - A Diversified Superbug
Edited by Mr. Yashwant Kumar
ISBN 978-953-307-781-9
Hard cover, 576 pages
Publisher InTech
Published online 20, January, 2012
Published in print edition January, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Salmonella is an extremely diversified genus, infecting a range of hosts, and comprised of two species:
enterica and bongori. This group is made up of 2579 serovars, making it versatile and fascinating for
researchers drawing their attention towards different properties of this microorganism. Salmonella related
diseases are a major problem in developed and developing countries resulting in economic losses, as well as
problems of zoonoses and food borne illness. Moreover, the emergence of an ever increasing problem of
antimicrobial resistance in salmonella makes it prudent to unveil different mechanisms involved. This book is
the outcome of a collaboration between various researchers from all over the world. The recent advancements
in the field of salmonella research are compiled and presented.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Lucky H. Moehario, Enty Tjoa, Veronica N. K. D. Kalay and Angela Abidin (2012). Antibiotic Susceptibility
Patterns of Salmonella Typhi in Jakarta and Surrounding Areas, Salmonella - A Diversified Superbug, Mr.
Yashwant Kumar (Ed.), ISBN: 978-953-307-781-9, InTech, Available from:
http://www.intechopen.com/books/salmonella-a-diversified-superbug/antibiotic-susceptibility-patterns-of-
salmonella-typhi-in-jakarta-and-surrounding-areas-
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
